Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2013 Oct;15(10):362.
doi: 10.1007/s11926-013-0362-y.

Polymorphism of HLA-B27: 105 subtypes currently known

Affiliations
Review

Polymorphism of HLA-B27: 105 subtypes currently known

Muhammad Asim Khan. Curr Rheumatol Rep. 2013 Oct.

Abstract

HLA-B27 has a high degree of genetic polymorphism, with 105 known subtypes, named HLA-B*27:01 to HLA-B*27:106, encoded by 132 alleles. The most common subtypes associated with ankylosing spondylitis are HLA-B*27:05 (Caucasians), HLA-B*27:04 (Chinese), and HLA-B*27:02 (Mediterranean populations). For Chinese populations, HLA-B*27:04 is associated with a greater ankylosing spondylitis risk than HLA-B*27:05. Two subtypes, HLA-B27*06 and HLA-B27*09, seem to have no disease association. These differential disease associations of HLA-B27 subtypes, and the recent discovery that ERAP1 is associated with ankylosing spondylitis for patients with HLA-B27, have increased attempts to determine the function of HLA-B27 in disease pathogenesis by studying hemodynamic features of its protein structure, alterations of its peptidome, aberrant peptide handling, and associated molecular events. However, after 40 years we still do not fully know how HLA-B27 predisposes to ankylosing spondylitis and related spondyloarthritis.

PubMed Disclaimer

References

    1. Rev Immunogenet. 1999;1(1):105-23 - PubMed
    1. Lancet. 1976 Feb 28;1(7957):483 - PubMed
    1. J Rheumatol. 1995 Oct;22(10):1884-90 - PubMed
    1. Nat Med. 2012 Jul 01;18(7):1069-76 - PubMed
    1. Arthritis Rheum. 1989 Sep;32(9):1135-41 - PubMed

Substances

LinkOut - more resources